Oregon Health & Science University
Oregon Health & Science University (OHSU) is Oregon’s only academic health center, encompassing three hospitals, four professional schools and a premier biomedical research portfolio with strengths in cancer, neuroscience and rare disorders. The OHSU School of Medicine Departments of Molecular and Medical Genetics and Neurology are comprised of faculty who focus on research, training, and comprehensive patient care, including pediatric and adult genetic disorders, neurogenetics, molecular genetics, inborn errors of metabolism, cancer genetics, and pediatric and adult movement disorders.
Drs. Hayflick and Hogarth lead a research program that spans basic, translational and clinical investigations in NBIA. In addition to discovering five NBIA genes, the OHSU team has defined the clinical, genetic and radiographic features of PKAN, delineated the distinctive features of major forms of NBIA, and championed open collaborations in order to advance the field of NBIA research. Hayflick and Hogarth have longstanding productive and highly valued collaborations with other TIRCON consortium members (Nardocci, Sibon, Chinnery, Vichinsky, Prokisch, Valenti and Kmiec).
Main tasks in the consortium
The OHSU NBIA team will be active partners in all eight work packages. We are internationally recognized for our two decades of work in NBIA and serve as an expert resource for patient care issues, which will benefit efforts for study recruitment, and for basic and translational research activities in the NBIA field. We have cultivated longstanding and vigorous engagement with the NBIA Disorders Association, serving on their Scientific and Medical Advisory Board, and with Hoffnungsbaum e.V.
• Partner in WP1, WP2, WP3, WP4, WP5, WP6